Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?

Journal of Nuclear Medicine

Volumn 50, Issue 1, 2009, Pages 24-29

  Abgral, Ronan ^a   Querellou, Solène ^a   Potard, Gaël ^a   Le Roux, Pierre Yves ^a   Le Duc Pennec, Alexandra ^a   Marianovski, Remi ^a   Pradier, Olivier ^a   Bizais, Yves ^a   Kraeber Bodéré, Françoise ^b   Salaun, Pierre Y ^a  

^a BREST UNIVERSITY HOSPITAL   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Fluorodeoxyglucose; Head and neck cancer; Positron emission tomography; Squamous cell carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG UPTAKE; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY COMPUTER ASSISTED TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; CLINICAL TRIAL; HEAD AND NECK TUMOR; LABORATORY DIAGNOSIS; METASTASIS; MIDDLE AGED; PATHOLOGY; TUMOR RECURRENCE;

CARCINOMA, SQUAMOUS CELL; FALSE NEGATIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58249112149     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.055806     Document Type: Article

References (27)

1. Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51:571-578.
2. Leemans CR, Tiwari R, Nauta JJP, van der Waal DDS, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer. 1994;73:187-190.
3. Lell M, Baum U, Greess H, et al. Head and neck tumors: imaging recurrent tumor and post-therapeutic changes with CT and MRI. Eur J Radiol. 2000;33:239-247.
4. Haas I, Hauser U, Ganzer U. The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol. 2001;258:177-183.
5. Hanasono MM, Kunda LD, Segall GM, et al. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope. 1999;109:880-885.
6. 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. Am J Neuroradiol. 1998;19:1189-1196.
7. 18F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol. 2002;20:4199-4208.
8. 18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management. Cancer. 2003;98:2257-2265.
9. 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med. 2003;44:198-206.
10. Stokkel MP, Terhaard CH, Hordijk GJ, van Rijk PP. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med. 1999;26:767-773.
11. Terhaard CH, Bongers V, van Rijk PP, Hordijk GJ. F-18-fluoro-deoxy- glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck. 2001;23:933-941.
12. 18fluoro- fluorodeoxyglucose positron emission tomography improve recurrence detection in patients cured of head and neck squamous cell carcinoma with negative clinical follow up? Head Neck. 2007;29:1115-1120.
13. Goodwin WJ. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: When do the ends justify the means? Laryngoscope. 2000;110:1-18.
14. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers, V.2.2008. Available at: http://www.nccn.org/ professionals/physician-gls/PDF/head-and-neck.pdf. Accessed November 20, 2008.
15. Schwartz DL, Barker J Jr, Chansky K, et al. Postradiotherapy surveillance practice for head and neck squamous cell carcinoma: too much for too little? Head Neck. 2003;25:990-999.
16. Wahl RL. Targeting glucose transporters for tumor imaging: "sweet" idea, "sour" result. J Nucl Med. 1996;37:1038-1041.
17. Ritoe SC, Krabbe PF, Kaanders JH, van den Hoogeb FJ, Verbeek AL, Marres HA. Value of routine follow up for patients cured of laryngeal carcinoma. Cancer. 2004;101:1382-1389.
18. Lowe VJ, Boyd JH, Dunphy FR, et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol. 2000;18:651-658.
19. Bombarderi E, Crippa F. The increasing impact of PET in the diagnostic work-up of cancer patients. In: Freeman L, ed. Nuclear Medicine Annual 2002. Philadelphia, PA: Lippincott Williams and Wilkins; 2002:75-121.
20. Kubota K, Yokoyama J, Yamaguchi K, et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging. 2004;31:590-595.
21. 18FFDG PET/CT in the treatment of head and neck cancers: posttherapy evaluation and pitfalls. AJR. 2005;184:589-597.
22. Isles MG, McConkey C, Mehanna HM. A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol. 2008;33:210-222.
23. Liu T, Xu W, Yan WL, Ye M, Bai YR, Huang G. FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review. Radiother Oncol. 2007;85:327-335.
24. 18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol. 2006;24:4367-4368.
25. Mitsuhashi N, Hayakawa K, Hasegawa M, et al. Clinical FDG-PET in diagnosis and evaluation of radiation response of patients with nasopharyngeal tumor. Anticancer Res. 1998;18:2827-2832.
26. Greven KM, Williams DW III, Keyes JW Jr, et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer. 1994;74:1355-1359.
27. Ryan WR, Willard EF, Quynh-Thu L, Harlan AP. Positron-emission tomography for surveillance of head and neck cancer. Laryngoscope. 2005;115:645-650.